All Posts

Hi Facecoachers, The clock is officially ticking for every practitioner operating in New South Wales. On November 5, 2026, the new Medicines, Poisons and Therapeutic Goods Regulation 2026 (NSW) takes full effect, replacing the ageing 1966 framework. For those of us working in non-surgical cosmetic medicine, this isn't just another administrative checkbox. It introduces a dedicated, much stricter legal regime specifically governing cosmetic use substances: from botulinum toxin

Hi Facecoachers, We are operating in a new era of cosmetic medicine. The days of "see a line, fill a line" without looking at the person behind the concern are long gone. If you’ve been following the updates from AHPRA and the Medical Board of Australia, you know that the focus has shifted heavily toward patient safety, psychological screening, and ethical practice. At the heart of these changes is the identification of Body Dysmorphic Disorder (BDD). It’s no longer just "goo

Hi Facecoachers, Transitioning into aesthetic medicine is one of the most common career pivots we see among registered nurses today. The demand for non-surgical cosmetic procedures is surging across Australia, but so is regulatory scrutiny. If you are wondering how to become a cosmetic nurse who operates safely, legally, and profitably, you need more than a weekend Botox certificate. You need a rigorous grounding in clinical governance, AHPRA compliance, and patient safety. I

description: "illegal retatrutide is hospitalising patients. learn why cosmetic practitioners must proactively screen for black-market peptides to ensure patient safety." The Australian cosmetic and weight-loss landscape has reached a critical regulatory inflection point in 2026. While practitioners focus on clinical outcomes and patient satisfaction, a shadow market of unapproved peptides: specifically retatrutide: is creating a public health crisis that is now landing pati

Hi Facecoachers, The UK’s MHRA just issued a significant safety alert regarding all botulinum toxin type A products. This isn't just "regulatory noise" from overseas; it’s a critical clinical update that has direct implications for how we practice here in Australia. The alert follows reports of rare cases of iatrogenic botulism. This occurs when the toxin’s effect spreads beyond the intended injection site, leading to systemic symptoms that can become life-threatening. As we

Hi Facecoachers, If you’ve spent any time on social media lately, you’ve likely seen the panic. One day, a clinic is posting about their latest “lip flip” special, and the next, they’ve scrubbed their entire feed after a letter from a regulator. The confusion between AHPRA (Australian Health Practitioner Regulation Agency) and the TGA (Therapeutic Goods Administration) is real, and frankly, it’s understandable. We are working in one of the most heavily scrutinized sectors of

Hi Facecoachers, Let’s be honest: 2026 has been a wild ride for our industry. Between the evolving ahpra cosmetic guidelines and the TGA’s laser focus on how we talk about S4 medicines, staying compliant feels like a full-time job on top of a full-time clinic. I’ve been speaking with a lot of you lately who are feeling the heat. It’s not just about the fear of a fine anymore; it’s about protecting your registration and your professional reputation. AHPRA isn't just "watching"

Hi Facecoachers, We’ve all been there. You have a "regular" in the chair. They’ve been seeing you for three years, you know their kids' names, and you could probably map their facial anatomy in your sleep. It’s tempting to skip the "boring" paperwork and get straight to the transformation. But here is the hard truth: skipping the intake form: even for one appointment: is how we miss the tiny clinical red flags that lead to the biggest headaches. I’m talking about delayed onse

Hi Facecoachers, The regulatory landscape in 2026 is, frankly, a bit of a minefield. Between the TGA’s absolute ban on advertising Schedule 4 (S4) medicines and AHPRA’s strict new standards for cosmetic procedures, it’s easy to feel like you’re walking on eggshells every time you want to post a result on Instagram. We all want to showcase our work. It’s how patients find us and how we build trust. But the rules have changed significantly over the last two years. What was "gre

In the rapidly evolving landscape of Australian aesthetic medicine, the transition from a "beauty-centric" model to a rigorous "medical-clinical" model is no longer optional. For AHPRA-registered doctors and nurses, the responsibility of performing non-surgical cosmetic procedures, such as the administration of Botulinum toxins, soft tissue fillers, and high-energy laser treatments, carries significant regulatory and ethical weight. At the core of this professional shift is a

The Australian cosmetic and weight-loss landscape has reached a critical regulatory inflection point in 2026. While practitioners focus on clinical outcomes and patient satisfaction, a shadow market of unapproved peptides: specifically retatrutide: is creating a public health crisis that is now landing patients in emergency departments across the country. Following the July 20, 2026, broadcast of the ABC 4 Corners documentary, "The health trends outpacing regulation," the ful

The landscape of non-surgical cosmetic medicine in Australia has undergone a seismic shift. As we progress through 2026, the era of "relaxed" social media marketing and informal prescribing arrangements is officially over. The Therapeutic Goods Administration (TGA) and the Australian Health Practitioner Regulation Agency (AHPRA) have moved beyond mere guidance, entering a sustained period of aggressive enforcement. For AHPRA-registered doctors and nurses, the stakes have neve